Wyeth business will boost Pfizer in Japan
This article was originally published in Scrip
Executive Summary
Pfizer expects its merger with Wyeth to give it a combined market share of around 6% in Japan, roughly half the figure in the US, reflecting Wyeth's relatively under-developed position in the country.